|
SYNTHES GMBH MAXFRAME(TM) FULL RING 180MM ALUMINUM; APPLIANCE, FIXATION, NAIL/BLADE/PLATE COMBINATION, MULTIPLE COMPONENT
|
Back to Search Results |
|
| Catalog Number |
03.312.180 |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
08/01/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.D9: complainant part is expected to be returned for manufacturer review/investigation, but has yet to be received.H3, h4, h6: without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
Device report from synthes reports an event in australia as follows: it was reported that the patient had a maxframe placed on (b)(6), 2022.It has had a few revisions over its time.On (b)(6), 2023, the original distal ring was cracked where one of the wires was placed, resulting in an unstable frame.The plan was finished, but the surgeon would have liked to have done a few more corrections.An open reduction/internal fixation was performed after the maxframe failed, and a tna tibial nail was put in on (b)(6), 2023.This report involves one maxframe(tm) full ring 180mm aluminum.This is report 1 of 1 for (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
It was further reported that original maxframe was placed on (b)(6) 2022.No programming was added at this stage for correction.Second stage maxframe was on (b)(6) 2023 added foot support kit and further distal wire fixation.Ran treatment plan for maxframe at this stage.Then completed a strut swap exchange on the (b)(6) 2023 continuing treatment plan.Then maxframe failed on the (b)(6) 2023 as described and removed and last operation occurred on the (b)(6) 2023 where patient was revised with a tibial nail advanced.It is confirmed that none of the original components of maxframe were removed/revised up until the (b)(6) 2023.The patient timeline reflects procedures to further the progress of the patient.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: if information is obtained that was not available for this medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H3, h6: the device was received, the investigation is in progress, no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H3, h6: part # 03.312.180; synthes lot # h432437; supplier lot # n/a; release to warehouse date: 12 oct 2017; manufactured by: synthes brandywine.No ncrs were generated during production.Review of the device history record(s) showed that there were no issues during the manufacture of this product, and any sub-components, which would contribute to this complaint condition.The product was returned to depuy synthes for evaluation.The depuy synthes team conducted a visual inspection of the returned device.Visual analysis of the returned sample and review of the photographic evidence revealed that the maxframe full ring ø180 al has a transversal fracture across the inner hole ih-39.Additionally, transversal scratches can be seen across multiple holes and the overall color of the device appears to be faded.No other defects that could have contributed to the reported event were observed.With the provided information it is not possible to determine the cause of the observed breakage condition.The mode of failure of the device could be multi-factorial and consideration must be given to all other potential influences such as surgical process and patient variables (e.G.Activity level and use).A dimensional inspection for the maxframe full ring ø180 al was unable to be performed due to post manufacturing damage.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.The overall complaint was confirmed as the observed condition of the maxframe full ring ø180 al would contribute to the complained device issue.There is no indication that a design or manufacturing issue has caused the complaint condition and hence the root cause cannot be determined.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|